Guitta Maki

2.9k total citations · 1 hit paper
24 papers, 2.3k citations indexed

About

Guitta Maki is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Guitta Maki has authored 24 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 6 papers in Oncology and 6 papers in Hematology. Recurrent topics in Guitta Maki's work include Immune Cell Function and Interaction (14 papers), CAR-T cell therapy research (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Guitta Maki is often cited by papers focused on Immune Cell Function and Interaction (14 papers), CAR-T cell therapy research (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Guitta Maki collaborates with scholars based in France, United States and Canada. Guitta Maki's co-authors include Hans-G. Klingemann, Jiang-Hong Gong, Ying K. Tam, Ed Robert Blazek, Hans-Georg Klingemann, Jeffrey Martinson, Torsten Tonn, Arpita Maiti, Pauline Johnson and Elaine K. Wong and has published in prestigious journals such as Science, Blood and The Journal of Immunology.

In The Last Decade

Guitta Maki

24 papers receiving 2.2k citations

Hit Papers

Characterization of a human cell line (NK-92) with phenot... 1994 2026 2004 2015 1994 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guitta Maki France 19 1.6k 1.2k 412 308 195 24 2.3k
Cory L. Ahonen United States 16 2.1k 1.3× 1.0k 0.9× 542 1.3× 258 0.8× 330 1.7× 19 3.0k
Robbert van der Voort Netherlands 28 1.4k 0.8× 1.1k 0.9× 658 1.6× 281 0.9× 123 0.6× 43 2.4k
Gundram Jung Germany 31 1.7k 1.0× 1.4k 1.2× 871 2.1× 323 1.0× 136 0.7× 114 2.9k
Maria Berg United States 19 1.6k 1.0× 1.2k 1.0× 454 1.1× 327 1.1× 112 0.6× 41 2.2k
Madhav V. Dhodapkar United States 23 1.8k 1.1× 1.1k 0.9× 593 1.4× 671 2.2× 138 0.7× 39 2.6k
Victor Peperzak Netherlands 21 1.4k 0.8× 486 0.4× 699 1.7× 316 1.0× 119 0.6× 42 2.1k
Alessandra Dondero Italy 28 2.2k 1.3× 1.2k 1.0× 442 1.1× 172 0.6× 110 0.6× 42 2.8k
Gabriella Pietra Italy 34 3.4k 2.1× 1.7k 1.4× 549 1.3× 244 0.8× 373 1.9× 77 4.1k
Mie Nieda Japan 31 2.5k 1.5× 1.4k 1.2× 386 0.9× 301 1.0× 140 0.7× 75 3.2k
Marina Ferrarini Italy 29 1.1k 0.7× 463 0.4× 902 2.2× 311 1.0× 257 1.3× 66 2.7k

Countries citing papers authored by Guitta Maki

Since Specialization
Citations

This map shows the geographic impact of Guitta Maki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guitta Maki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guitta Maki more than expected).

Fields of papers citing papers by Guitta Maki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guitta Maki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guitta Maki. The network helps show where Guitta Maki may publish in the future.

Co-authorship network of co-authors of Guitta Maki

This figure shows the co-authorship network connecting the top 25 collaborators of Guitta Maki. A scholar is included among the top collaborators of Guitta Maki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guitta Maki. Guitta Maki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frémont, Grégoire Martin de, Maud Salmona, Rémi Bertinchamp, et al.. (2022). Human adenoviral (HAdV) chronic arthritis expands the infectious spectrum of primary agammaglobulinemia. Virology Journal. 19(1). 172–172. 1 indexed citations
2.
Moins‐Teisserenc, Hélène, Vincent Audigier, Mourad Benyamina, et al.. (2021). Severe Altered Immune Status After Burn Injury Is Associated With Bacterial Infection and Septic Shock. Frontiers in Immunology. 12. 586195–586195. 54 indexed citations
3.
Farge, Dominique, Lucas C. M. Arruda, Emmanuel Clave, et al.. (2017). Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients. Journal of Hematology & Oncology. 10(1). 21–21. 53 indexed citations
4.
Lambert, Jérôme, Marie Roelens, E. Maubec, et al.. (2016). Ipilimumab reshapes T cell memory subsets in melanoma patients with clinical response. OncoImmunology. 5(7). 1136045–1136045. 18 indexed citations
5.
Servais, Sophie, Étienne Lengliné, Raphaël Porcher, et al.. (2014). Long-Term Immune Reconstitution and Infection Burden after Mismatched Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 20(4). 507–517. 58 indexed citations
6.
Moins‐Teisserenc, Hélène, Emmanuel Clave, Corinne Douay, et al.. (2014). CD158k Is a Reliable Marker for Diagnosis of Sézary Syndrome and Reveals an Unprecedented Heterogeneity of Circulating Malignant Cells. Journal of Investigative Dermatology. 135(1). 247–257. 46 indexed citations
7.
Busson, Marc, Catherine Scieux, Régis Peffault de Latour, et al.. (2014). Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation. Haematologica. 99(12). 1860–1867. 47 indexed citations
8.
Xhaard, Aliénor, Hélène Moins‐Teisserenc, Marc Busson, et al.. (2014). Reconstitution of regulatory T-cell subsets after allogeneic hematopoietic SCT. Bone Marrow Transplantation. 49(8). 1089–1092. 21 indexed citations
9.
Naji, Abderrahim, Catherine Menier, Fabio Morandi, et al.. (2014). Binding of HLA-G to ITIM-Bearing Ig-like Transcript 2 Receptor Suppresses B Cell Responses. The Journal of Immunology. 192(4). 1536–1546. 130 indexed citations
10.
Glauzy, Salomé, Juliette Soret, Isabelle Fournier, et al.. (2014). Impact of acute and chronic graft-versus-host disease on human B-cell generation and replication. Blood. 124(15). 2459–2462. 18 indexed citations
11.
Maki, Guitta, Gregory M. Hayes, Abderrahim Naji, et al.. (2008). NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G. Leukemia. 22(5). 998–1006. 78 indexed citations
12.
Müller, Tina, Christoph Uherek, Guitta Maki, et al.. (2007). Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells. Cancer Immunology Immunotherapy. 57(3). 411–423. 180 indexed citations
13.
Xu, Xiulong, Geetha Rao, Helen Ding, et al.. (2006). Clinicopathological Significance of Major Histocompatibility Complex Class I-Related Chain A and B Expression in Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 91(7). 2704–2712. 42 indexed citations
14.
Blazek, Ed Robert, et al.. (2006). Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133− cells, and the CD133+ sector is enlarged by hypoxia. International Journal of Radiation Oncology*Biology*Physics. 67(1). 1–5. 217 indexed citations
15.
Maki, Guitta, Y.K. Tam, Leanne Berkahn, & Klingemann Hg. (2003). Ex vivo purging with NK-92 prior to autografting for chronic myelogenous leukemia. Bone Marrow Transplantation. 31(12). 1119–1125. 15 indexed citations
16.
Maki, Guitta, Hans-G. Klingemann, Jeffrey Martinson, & Ying K. Tam. (2001). Factors Regulating the Cytotoxic Activity of the Human Natural Killer Cell Line, NK-92. Journal of Hematotherapy & Stem Cell Research. 10(3). 369–383. 214 indexed citations
17.
Maki, Guitta. (2001). Ex Vivo Purging of Stem Cell Autografts Using Cytotoxic Cells. Journal of Hematotherapy & Stem Cell Research. 10(4). 545–551. 9 indexed citations
18.
Tam, Ying K., et al.. (1999). Characterization of Genetically Altered, Interleukin 2-Independent Natural Killer Cell Lines Suitable for Adoptive Cellular Immunotherapy. Human Gene Therapy. 10(8). 1359–1373. 176 indexed citations
19.
Maki, Guitta, Gerald Krystal, G J Dougherty, Fumio Takei, & H-G Klingemann. (1998). Induction of sensitivity to NK-mediated cytotoxicity by TNF-α treatment: possible role of ICAM-3 and CD44. Leukemia. 12(10). 1565–1572. 21 indexed citations
20.
Klingemann, Hans-G., et al.. (1994). Establishment and Characterization of a Human Leukemic Cell Line (SR-91) with Features Suggestive of Early Hematopoietic Progenitor Cell Origin. Leukemia & lymphoma. 12(5-6). 463–470. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026